Author: Dr. David Lowemann

Rethinking altruistic punishment: New experimental insights

A research team developed a new experimental game to explore whether people avoid witnessing selfish behavior to evade punishing others or simply to avoid confronting unfairness. The study found that avoidance is driven by both the desire to not acknowledge inequality and the wish to prevent confrontation, suggesting that altruistic punishment may be less common […]

Published on January 27, 2025

New Drug Preserves Muscle in Wegovy Patients

Veru said on Monday its experimental drug, in combination with Novo Nordisk’s weight-loss treatment Wegovy, helped preserve muscle in older patients with obesity, meeting the main goal of a mid-stage study. The study was testing Veru’s oral drug, enobosarm, in patients aged… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is […]

Published on January 27, 2025

Adderall Shortage Sparks Scramble for Alternatives

Adderall shortages have prompted doctors to switch kids with attention-deficit/hyperactivity disorder (ADHD) to other forms of stimulant medication. Adderall prescription fills for children and teens plunged after the U.S. Food and Drug Administration (FDA) announced a… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for […]

Published on January 27, 2025